Greenberg Richard S 4/A
4/A · NEXIEN BIOPHARMA, INC. · Filed Aug 25, 2020
Insider Transaction Report
Form 4/AAmended
Greenberg Richard S
DirectorEVP and Chairman10% Owner
Transactions
- Conversion
Common Stock
2020-08-12$0.01/sh+1,797,192$25,161→ 2,685,192 total
Holdings
- 2,500,000
Options to purchase common stock (right to buy)
Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ Common Stock (2,500,000 underlying) - 150,000
Options to purchase common stock (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (150,000 underlying) - 100,000
Options to purchase common stock (right to buy)
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (100,000 underlying)